|
US4440859A
(en)
|
1977-05-27 |
1984-04-03 |
The Regents Of The University Of California |
Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
|
|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
IE53176B1
(en)
|
1978-12-22 |
1988-08-17 |
Biogen Nv |
Recombinant dna molecules and their method of production
|
|
US4530901A
(en)
|
1980-01-08 |
1985-07-23 |
Biogen N.V. |
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
|
|
US4342566A
(en)
|
1980-02-22 |
1982-08-03 |
Scripps Clinic & Research Foundation |
Solid phase anti-C3 assay for detection of immune complexes
|
|
US4678751A
(en)
|
1981-09-25 |
1987-07-07 |
Genentech, Inc. |
Hybrid human leukocyte interferons
|
|
US4766075A
(en)
|
1982-07-14 |
1988-08-23 |
Genentech, Inc. |
Human tissue plasminogen activator
|
|
US4582800A
(en)
|
1982-07-12 |
1986-04-15 |
Hoffmann-La Roche Inc. |
Novel vectors and method for controlling interferon expression
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
|
US4677063A
(en)
|
1985-05-02 |
1987-06-30 |
Cetus Corporation |
Human tumor necrosis factor
|
|
US4810648A
(en)
|
1986-01-08 |
1989-03-07 |
Rhone Poulenc Agrochimie |
Haloarylnitrile degrading gene, its use, and cells containing the gene
|
|
US4897445A
(en)
|
1986-06-27 |
1990-01-30 |
The Administrators Of The Tulane Educational Fund |
Method for synthesizing a peptide containing a non-peptide bond
|
|
ATE183513T1
(de)
|
1993-06-03 |
1999-09-15 |
Therapeutic Antibodies Inc |
Herstellung von antikörperfragmenten
|
|
AUPM322393A0
(en)
|
1993-12-24 |
1994-01-27 |
Austin Research Institute, The |
Mucin carbohydrate compounds and their use in immunotherapy
|
|
ES2203782T3
(es)
|
1996-01-17 |
2004-04-16 |
Imperial College Innovations Limited |
Inmunoterapia que utiliza linfocitos t citotoxicos (ctl).
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US20020177551A1
(en)
*
|
2000-05-31 |
2002-11-28 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
|
US20020061552A1
(en)
|
1999-12-17 |
2002-05-23 |
Dong Yan |
Mammalian dishevelled-associated proteins
|
|
AU2001232204A1
(en)
|
2000-02-22 |
2001-09-03 |
Ahuva Nissim |
Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof
|
|
CA2404489A1
(en)
|
2000-03-27 |
2001-10-04 |
Technion Research And Development Foundation Ltd. |
Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
US20030144474A1
(en)
|
2000-06-05 |
2003-07-31 |
Sunol Molecular Corporation |
T cell receptor fusions and conjugates and methods of use thereof
|
|
WO2002007783A2
(en)
|
2000-07-20 |
2002-01-31 |
Regents Of The University Of Minnesota |
Radiolabeled immunotoxins
|
|
US7919467B2
(en)
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
US6867283B2
(en)
|
2001-05-16 |
2005-03-15 |
Technion Research & Development Foundation Ltd. |
Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells
|
|
US20050053918A1
(en)
|
2001-05-16 |
2005-03-10 |
Technion Research & Development Foundation Ltd. |
Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses
|
|
US20070134261A1
(en)
*
|
2001-12-03 |
2007-06-14 |
Hancock Robert E |
Effectors of innate immunity
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
US20030223994A1
(en)
|
2002-02-20 |
2003-12-04 |
Hoogenboom Henricus Renerus Jacobus Mattheus |
MHC-peptide complex binding ligands
|
|
US7311914B2
(en)
|
2002-08-13 |
2007-12-25 |
Ludwig Institute For Cancer Research |
MAGE-A4 antigenic peptides and uses thereof
|
|
US20040091503A1
(en)
*
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
AU2003254950A1
(en)
|
2002-08-26 |
2004-03-11 |
Kirin Beer Kabushiki Kaisha |
Peptides and drugs containing the same
|
|
NZ539225A
(en)
|
2002-10-09 |
2006-09-29 |
Avidex Ltd |
Single chain recombinant T cell receptors
|
|
ES2327229T3
(es)
|
2002-11-09 |
2009-10-27 |
Immunocore Ltd. |
Presentacion del receptor de linfocitos t.
|
|
US20040096982A1
(en)
|
2002-11-19 |
2004-05-20 |
International Business Machines Corporation |
Methods and apparatus for analysis of mass spectra
|
|
PT1581812E
(pt)
|
2003-01-06 |
2008-09-22 |
Wyeth Corp |
Composições e métodos para diagnóstico e tratamento de cancros do cólon
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
US20090304679A1
(en)
|
2004-05-27 |
2009-12-10 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
US20090233318A1
(en)
|
2004-12-28 |
2009-09-17 |
Weidanz Jon A |
Methods of assaying vaccine potency
|
|
US20090075304A1
(en)
|
2004-05-27 |
2009-03-19 |
Weidanz Jon A |
Methods of assaying vaccine potency
|
|
ATE461215T1
(de)
|
2005-09-05 |
2010-04-15 |
Immatics Biotechnologies Gmbh |
Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden
|
|
EP1760089B1
(en)
|
2005-09-05 |
2009-08-19 |
Immatics Biotechnologies GmbH |
Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine
|
|
WO2008021290A2
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
WO2008156655A2
(en)
|
2007-06-15 |
2008-12-24 |
Genelux Corporation |
Vaccinia virus vectors encoding a sodium-dependent transporter protein for imaging and/or treatment of tumors
|
|
WO2009026547A1
(en)
|
2007-08-22 |
2009-02-26 |
Receptor Logi, Ltd. |
Methods of assaying vaccine potency
|
|
ES2573458T3
(es)
|
2007-09-14 |
2016-06-08 |
Vrije Universiteit Brussel |
Mejoramiento de la capacidad estimulatoria de las células T de las células que presentan antígeno humano y su uso en vacunación
|
|
WO2009108372A2
(en)
|
2008-02-27 |
2009-09-03 |
Receptor Logic, Inc. |
Antibodies as t cell receptor mimics, methods of production and uses thereof
|
|
US20090263574A1
(en)
|
2008-04-21 |
2009-10-22 |
Quinn Daniel E |
Method of restoring an article
|
|
WO2009151487A1
(en)
|
2008-06-13 |
2009-12-17 |
Receptor Logic, Inc. |
Methods of assaying vaccine potency
|
|
DE102008049136B4
(de)
|
2008-09-26 |
2012-10-25 |
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. |
Neue Regulatoren des angeborenen Immunsystems
|
|
PL2172211T3
(pl)
|
2008-10-01 |
2015-05-29 |
Immatics Biotechnologies Gmbh |
Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka
|
|
EP2366162A1
(en)
*
|
2008-11-18 |
2011-09-21 |
Collabrx, Inc. |
Individualized cancer treatment
|
|
JP2013510586A
(ja)
|
2009-11-14 |
2013-03-28 |
チュウ、カン−ユウ |
アテローム性動脈硬化を治療及び／又は予防するための免疫調節方法及びシステム
|
|
US8506964B2
(en)
|
2010-02-05 |
2013-08-13 |
Cardiovax, Llc |
Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
EP2632955A1
(en)
|
2010-10-26 |
2013-09-04 |
Technion Research & Development Foundation Ltd. |
Antibodies which bind soluble t-cell receptor ligands
|
|
EP2637685A1
(en)
|
2010-11-12 |
2013-09-18 |
Cedars-Sinai Medical Center |
Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
|
|
CA2817548A1
(en)
|
2010-11-12 |
2012-05-18 |
Cedars-Sinai Medical Center |
Immunomodulatory compositions, methods and systems comprising immunogenic fragments of apob100
|
|
RU2013126626A
(ru)
|
2010-11-12 |
2014-12-20 |
Седарс-Синаи Медикал Сентер |
Иммуномодулирующие способы и системы для лечения и/или предотвращения гипертензий
|
|
CA2836299A1
(en)
*
|
2011-04-15 |
2012-10-18 |
Genelux Corporation |
Clonal strains of attenuated vaccinia viruses and methods of use thereof
|
|
WO2013057586A1
(en)
|
2011-10-19 |
2013-04-25 |
Oslo Universitetssykehus Hf |
Compositions and methods for producing soluble t - cell receptors
|
|
US9221876B2
(en)
*
|
2011-11-11 |
2015-12-29 |
Cardiovax, Llc |
Methods for treating kidney disease with fragments of ApoB-100
|
|
CN104105499A
(zh)
*
|
2011-12-09 |
2014-10-15 |
康肽德生物医药技术有限公司 |
芳香族阳离子肽及其用途
|
|
GB201208293D0
(en)
|
2012-05-11 |
2012-06-20 |
Circassia Ltd |
Hydrochlorice salt of peptide
|
|
GB201209862D0
(en)
*
|
2012-06-01 |
2012-07-18 |
Circassia Ltd |
Cladosporium peptides
|
|
EP2892544A4
(en)
*
|
2012-09-05 |
2016-11-02 |
Univ Virginia Patent Found |
TARGET PEPTIDES FOR THERAPY AND DIAGNOSIS OF COLORECTAL CARCINOMAS
|
|
WO2014071978A1
(en)
|
2012-11-08 |
2014-05-15 |
Roche Diagnostics Gmbh |
Nucleic acids encoding chimeric polypeptides for library screening
|
|
GB201301632D0
(en)
|
2013-01-30 |
2013-03-13 |
Imp Innovations |
Complement System
|
|
WO2014160275A2
(en)
*
|
2013-03-14 |
2014-10-02 |
Battell Memorial Institute |
Biomarkers for liver fibrosis
|
|
EP2808392A1
(en)
|
2013-05-28 |
2014-12-03 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Aptamers and use of the aptamers in the diagnosis and treatment of cancer
|
|
CN103739667B
(zh)
|
2013-09-24 |
2017-08-25 |
上海宇研生物技术有限公司 |
卵巢癌特异的肿瘤抗原肽及其制备方法
|
|
BR112016021004A2
(pt)
|
2014-03-14 |
2018-01-23 |
Immunocore Limited |
biblioteca de partículas; receptor de células t (tcr) isolado não natural; uso de uma biblioteca; método de obtenção de um receptor de células t que se liga especificamente a um antígeno de peptídeo; ácido nucleico; método de construção de uma biblioteca de partículas; método de obtenção de um receptor de células t que se liga especificamente a um antígeno de peptídeo; e partícula
|
|
HRP20211754T1
(hr)
*
|
2014-12-23 |
2022-03-04 |
Immatics Biotechnologies Gmbh |
Novi peptidi i kombinacije peptida za upotrebu u imunoterapiji protiv hepatocelularnog karcinoma (hcc) i drugih rakova
|
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
US20180179283A1
(en)
|
2015-06-08 |
2018-06-28 |
Adicet Bio Inc. |
T cell receptor like antibodies having fine specificity
|
|
HRP20211493T1
(hr)
|
2016-04-08 |
2022-01-21 |
Adaptimmune Limited |
Receptori t stanica
|
|
CN116239669A
(zh)
|
2016-04-08 |
2023-06-09 |
艾达普特免疫有限公司 |
T细胞受体
|
|
ES2991142T3
(es)
|
2016-04-08 |
2024-12-02 |
Adaptimmune Ltd |
Receptores de linfocitos T
|
|
WO2018022573A1
(en)
|
2016-07-27 |
2018-02-01 |
Sharp Laboratories Of America, Inc. |
Wireless telecommuncations methods and apparatus using system information value tag
|
|
US20200325244A1
(en)
|
2020-05-18 |
2020-10-15 |
Abexxa Biologics, Inc. |
Antibodies and methods of use thereof
|
|
JP7303750B2
(ja)
|
2017-01-24 |
2023-07-05 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
癌における非古典的ｈｌａ－ｉおよびネオ抗原を含む複合体を標的とするための方法および組成物
|
|
EP3636761B1
(en)
|
2017-06-05 |
2024-07-31 |
Mie University |
Antigen-binding protein recognizing mage-a4-derived peptide
|
|
BR112019028280A2
(pt)
|
2017-07-04 |
2020-07-14 |
Curevac Ag |
moléculas de ácido nucleico
|
|
MX2020001879A
(es)
|
2017-08-18 |
2020-07-29 |
Gritstone Oncology Inc |
Proteínas de fijación al antígeno que se dirigen a antígenos compartidos.
|
|
WO2019051001A1
(en)
|
2017-09-06 |
2019-03-14 |
California Institute Of Technology |
SIGNALING AND BIFUNCTIONAL RECEPTORS HAVING ANTIGENS (SABR)
|
|
JP2021508475A
(ja)
|
2017-12-28 |
2021-03-11 |
グリットストーン オンコロジー インコーポレイテッド |
共有抗原を標的とする抗原結合タンパク質
|
|
CA3097399A1
(en)
|
2018-04-19 |
2019-10-24 |
The Board Of Regents, The University Of Texas System |
T cell receptors with mage-b2 specificity and uses thereof
|
|
TW202000907A
(zh)
|
2018-05-23 |
2020-01-01 |
美商葛利史東腫瘤科技公司 |
共有抗原
|
|
US20200291116A1
(en)
|
2020-05-18 |
2020-09-17 |
Abexxa Biologics, Inc. |
Antibodies and methods of use thereof
|
|
US20200291128A1
(en)
|
2020-05-18 |
2020-09-17 |
Abexxa Biologics, Inc. |
Antibodies and methods of use thereof
|
|
US20200291127A1
(en)
|
2020-05-18 |
2020-09-17 |
Abexxa Biologics, Inc. |
Antibodies and methods of use thereof
|